SCHEMBL6346852

SCHEMBL6346852

CCN1C(=O)c2cccc3cc(S(=O)(=O)N(C)C)cc(c23)C1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 3/20 0.60
▸ CLTC Q00610 12/20 0.54
▸ ALDH1A1 P00352 2/20 0.49
▸ CASP1 P29466 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ HPGD P15428 1/20 0.49
▸ MPI P34949 1/20 0.49
▸ CACNA1B Q00975 1/20 0.49
▸ APBA1 Q02410 1/20 0.49
▸ CYP2D6 P10635 1/20 0.48
▸ FTO Q9C0B1 1/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HEXA P06865 1/20 0.47
▸ HEXB P07686 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3856081 0.82 MEN1 (0.65) CLTCALDH1A1SMN1; SMN2HPGDCYP2D6
SCHEMBL6347710 0.78 CYP1B1 (0.75) CYP1B1CLTCALDH1A1CASP1SMN1; SMN2
SCHEMBL117049 0.77 CYP1B1 (1.00) CYP1B1ALDH1A1CASP1SMN1; SMN2HPGD
SCHEMBL14463946 0.76 PKM (0.67) CLTCALDH1A1CASP1SMN1; SMN2HPGD
SCHEMBL13893856 0.75 CYP1B1 (0.71) CYP1B1CLTCALDH1A1CASP1SMN1; SMN2
SCHEMBL14973498 0.74 KDM4E (0.51) CLTCALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL6345888 0.74 BRD4 (0.64) CYP1B1CLTCALDH1A1CASP1SMN1; SMN2
SCHEMBL14636558 0.71 CLTC (0.79) CLTCHPGDNPSR1
SCHEMBL4908838 0.69 PARK7 (0.57) ALDH1A1CASP1SMN1; SMN2MEN1KMT2A
SCHEMBL14636868 0.68 CLTC (0.78) CLTCALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173226-B2 Polymerizable compound , polyethylene glycol mono(meth)acrylate, a polystyrene oligomer having a methacryloyl group at one terminal, acrylic macromonomer imides FUJIFILM CORPORATION (JP) 2012-05-08 — — US disclosed
US-20090214797-A1 INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME FUJIFILM CORPORATION (JP) 2009-08-27 — — US disclosed
US-20090214797-A1 INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME FUJIFILM CORPORATION (JP) 2009-08-27 — — US disclosed
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2008-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD CNOT1, CCNT1, SCO2 CYP1B1 169/4885CLTC 362/4885ALDH1A1 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback